<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "3: Various ", fill: "#008000"},
{source: "3: Various ", target: "3: differ materially from", fill: "#008000"},
{source: "3: differ materially from", target: "3: expectations such as", fill: "#008000"},
{source: "3: expectations such as", target: "3: regulations affecting", fill: "#008000"},
{source: "3: regulations affecting", target: "3: operations", fill: "#008000"},
{source: "3: operations", target: "3: acquisitions", fill: "#008000"},
{source: "3: acquisitions", target: "3: complementary operations", fill: "#008000"},
{source: "3: complementary operations", target: "3: existing operations", fill: "#008000"},
{source: "3: existing operations", target: "3: market forces", fill: "#008000"},
{source: "3: market forces", target: "3: contingencies", fill: "#008000"},
{source: "3: contingencies", target: "3: necessitate", fill: "#008000"},
{source: "3: necessitate", target: "3: fluctuations", fill: "#008000"},
{source: "3: fluctuations", target: "3: investment", fill: "#008000"},
{source: "3: investment", target: "3: might materially affect", fill: "#008000"},
{source: "3: might materially affect", target: "3: financial condition", fill: "#008000"},
{source: "3: Various ", target: "6: competitive", fill: "#ff6fff"},
{source: "6: competitive", target: "6: principally on", fill: "#ff6fff"},
{source: "6: principally on", target: "6: product line", fill: "#ff6fff"},
{source: "6: product line", target: "6: manufacturing", fill: "#ff6fff"},
{source: "6: manufacturing", target: "6: technology", fill: "#ff6fff"},
{source: "6: technology", target: "6: selling prices", fill: "#ff6fff"},
{source: "6: competitive", target: "9: accounts", fill: "#555"},
{source: "9: accounts", target: "9: adversely", fill: "#555"},
{source: "9: accounts", target: "12: customer could", fill: "#8c92ac"},
{source: "12: customer could", target: "13: governmental", fill: "#69c"},
{source: "13: governmental", target: "13: approvals would materially harm", fill: "#69c"},
{source: "13: approvals would materially harm", target: "13: businesses", fill: "#69c"},
{source: "13: governmental", target: "14: environmental", fill: "#e03c31"},
{source: "14: environmental", target: "14: regulations", fill: "#e03c31"},
{source: "14: regulations", target: "14: governmental", fill: "#e03c31"},
{source: "14: governmental", target: "14: registration", fill: "#e03c31"},
{source: "14: environmental", target: "19: facility", fill: "#ca2c92"},
{source: "19: facility", target: "19: registered with", fill: "#ca2c92"},
{source: "19: registered with", target: "19: drug manufacturing", fill: "#ca2c92"},
{source: "19: facility", target: "31: difficulties", fill: "#fff5ee"},
{source: "31: difficulties", target: "31: procuring raw materials", fill: "#fff5ee"},
{source: "31: procuring raw materials", target: "31: such problems", fill: "#fff5ee"},
{source: "31: difficulties", target: "37: inability", fill: "#00416a"},
{source: "37: inability", target: "37: intellectual", fill: "#00416a"},
{source: "37: intellectual", target: "37: property could harm", fill: "#00416a"},
{source: "37: inability", target: "38: United States ", fill: "#6e7f80"},
{source: "38: United States ", target: "START_HERE", fill: "#6e7f80"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Investment Banking and Brokerage</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Environmental Services</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Military blockade</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Grant</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
    <tr>
      <td>Natural disaster</td>
    </tr>
    <tr>
      <td>Psychological state</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Arithmetic">Arithmetic</a></td>
      <td>Arithmetic (from Ancient Greek  ἀριθμός (arithmós) 'number', and  τική [τέχνη] (tikḗ [tékhnē]) 'art, craft') is an elementary part of mathematics that consists of the study of the properties of the traditional operations on numbers—addition, subtraction, multiplication, division, exponentiation, and extraction of roots. In the 19th century, Italian mathematician Giuseppe Peano formalized arithmetic with his Peano axioms, which are highly important to the field of mathematical logic today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Competitive_advantage">Competitive advantage</a></td>
      <td>In business, a competitive advantage is the attribute that allows an organization to outperform its competitors.\nA competitive advantage may include access to natural resources, such as high-grade ores or a low-cost power source, highly skilled labor, geographic location, high entry barriers, and access to new technology.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Manufacturing">Manufacturing</a></td>
      <td>Manufacturing is the creation or production of goods with the help of equipment, labor, machines, tools, and chemical or biological processing or formulation. It is the essence of secondary sector of the economy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Automotive_industry">Automotive industry</a></td>
      <td>The automotive industry comprises a wide range of companies and organizations involved in the design, development, manufacturing, marketing, and selling of motor vehicles. It is one of the world's largest industries by revenue (from 16 % such as in France up to 40 % to countries like Slovakia).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Murata_Manufacturing">Murata Manufacturing</a></td>
      <td>Murata Manufacturing Co., Ltd. (株式会社村田製作所, Kabushiki-gaisha Murata Seisakusho) is a Japanese manufacturer of electronic components, based in Nagaokakyo, Kyoto.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Adverse_effect">Adverse effect</a></td>
      <td>An adverse effect is an undesired harmful effect resulting from a medication or other intervention, such as surgery. An adverse effect may be termed a "side effect", when judged to be secondary to a main or therapeutic effect.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Adverse_possession">Adverse possession</a></td>
      <td>Adverse possession, sometimes colloquially described as "squatter's rights", is a legal principle in the Anglo-American common law under which a person who does not have legal title to a piece of property—usually land (real property)—may acquire legal ownership based on continuous possession or occupation of the property without the permission (licence) of its legal owner. The possession by a person is not adverse if they are in possession as a tenant or licensee of the legal owner.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Adverse_party">Adverse party</a></td>
      <td>An adverse party is an opposing party in a lawsuit under an adversary system of law.  In general, an adverse party is a party against whom judgment is sought or "a party interested in sustaining a judgment or decree." For example, the adverse party for a defendant is the plaintiff.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Hostile_witness">Hostile witness</a></td>
      <td>A hostile witness, also known as an adverse witness or an unfavorable witness, is a witness at trial whose  testimony on direct examination is either openly antagonistic or appears to be contrary to the legal position of the party who called the witness. This concept is used in the legal proceedings in the United States, and analogues of it exist in other legal systems in Western countries.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Diuretic">Diuretic</a></td>
      <td>Diuresis () is increased urination (polyuria) or, in the related word senses more often intended, the physiologic process that produces such an increase or the administration of medications to encourage that process. It involves extra urine production in the kidneys as part of the body's homeostatic maintenance of fluid balance.In healthy people, the drinking of extra water produces mild diuresis to maintain the body water  balance.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Adverse_event">Adverse event</a></td>
      <td>An adverse event (AE) is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unfavourable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product.AEs in patients participating in clinical trials must be reported to the study sponsor and if required could be reported to local ethics committee.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Customer_Profitability_Analysis">Customer Profitability Analysis</a></td>
      <td>Customer Profitability Analysis (in short CPA) is a management accounting and a credit underwriting method, allowing businesses and lenders to determine the profitability of each customer or segments of customers, by attributing profits and costs to each customer separately. CPA can be applied at the individual customer level (more time consuming, but providing a better understanding of business situation) or at the level of customer aggregates / groups (e.g.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Non-governmental_organization">Non-governmental organization</a></td>
      <td>A non-government organization (NGO) is an organization that generally is formed independent from government. They are typically nonprofit entities, and many of them are active in humanitarianism or the social sciences; they can also include clubs and associations that provide services to their members and others.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Government_of_India">Government of India</a></td>
      <td>The Government of India (ISO: Bhārat Sarkār) (often abbreviated as GoI; also known as the Central or Union Government), or simply the Centre, is the federal governing authority of the Republic of India created by the Constitution of India as the legislative, executive and judicial authority to govern the union of twenty eight states and eight union territories. The president acts as the head of state and is the highest figure of authority, nominally, of the nation however it is the prime minister who is the chief executive.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_non-governmental_organisations_in_India">List of non-governmental organisations in India</a></td>
      <td>This is a list of notable charitable projects and non-governmental organisations (NGOs) working in India or connected with Indian diaspora.\n\n\n== EDASHA FOUNDATION is a non govt company registered on 21 april 2022 under company act 2013 working towards imparting education to underprivileged children . ==</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Government-organized_non-governmental_organization">Government-organized non-governmental organization</a></td>
      <td>A government-organized non-governmental organization (GONGO) is a non-governmental organization that was set up or sponsored by a government in order to further its political interests and mimic the civic groups and civil society at home, or promote its international or geopolitical interests abroad.\n\n\n== History ==\nThe term GONGO had become established by the late 1980s, and it was suggested that it was first introduced by a group of Indonesian non-governmental organizations.Most contemporary attempts to understand GONGOs have come from studies of authoritarian contexts, where these organizations have proliferated as a deliberative strategy by the state to have a (corporatist) mechanism that feeds directly into a grassroots civic space.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Federal_government_of_the_United_States">Federal government of the United States</a></td>
      <td>The federal government of the United States (U.S. federal government or U.S. government) is the national government of the United States, a federal republic in North America, composed of 50 states, a city within a federal district (the city of Washington in the District of Columbia, where the entire federal government is based), five major self-governing territories and several island possessions. The federal government is composed of three distinct branches: legislative, executive, and judicial, whose powers are vested by the U.S. Constitution in the Congress, the president and the federal courts, respectively.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Vehicle_registration_plate">Vehicle registration plate</a></td>
      <td>A vehicle registration plate, also known as a number plate (British English), license plate (American English), or licence plate (Canadian English), is a metal or plastic plate attached to a motor vehicle or trailer for official identification purposes. All countries require registration plates for road vehicles such as cars, trucks, and motorcycles.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Aircraft_registration">Aircraft registration</a></td>
      <td>An aircraft registration is a code unique to a single aircraft, required by international convention to be marked on the exterior of every civil aircraft. The registration indicates the aircraft's country of registration, and functions much like an automobile license plate or a ship registration.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/ISBN">ISBN</a></td>
      <td>The International Standard Book Number (ISBN) is a numeric commercial book identifier that is intended to be unique. Publishers purchase ISBNs from an affiliate of the International ISBN Agency.An ISBN is assigned to each separate edition and variation (except reprintings) of a publication.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Voter_registration">Voter registration</a></td>
      <td>In electoral systems, voter registration (or enrollment) is the requirement that a person otherwise eligible to vote must register (or enroll) on an electoral roll, which is usually a prerequisite for being entitled or permitted to vote.\nThe rules governing registration vary between jurisdictions.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Discrimination_against_superheroes">Discrimination against superheroes</a></td>
      <td>Discrimination against superheroes is a common theme and plot element comic books and superhero fiction, usually as a way to explore the issue of superheroes operating in society or as commentary on other social concerns. Often in response to this are Registration Acts, fictional legislative bills that have been plot points used in various comic books and mediums which, when passed into law, enforce the regulation of extra-legal vigilante activity vs.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Health_facility">Health facility</a></td>
      <td>A health facility is, in general, any location where healthcare is provided. Health facilities range from small clinics and doctor's offices to urgent care centers and large hospitals with elaborate emergency rooms and trauma centers.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Telecommunications_facility">Telecommunications facility</a></td>
      <td>In telecommunications, a facility is defined by Federal Standard 1037C as:\n\nA fixed, mobile, or transportable structure, including (a) all installed electrical and electronic wiring, cabling, and equipment and (b) all supporting structures, such as utility, ground network, and electrical supporting structures.\nA network-provided service to users or the network operating administration.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Dysphagia">Dysphagia</a></td>
      <td>Dysphoria (from Ancient Greek  δύσφορος (dúsphoros) 'grievous'; from  δυσ- (dus-) 'bad, difficult', and  φέρω (phérō) 'to bear') is a profound state of unease or dissatisfaction. It is the opposite of euphoria.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Intellectual_property_infringement">Intellectual property infringement</a></td>
      <td>An intellectual property (IP) infringement is the infringement or violation of an intellectual property right. There are several types of intellectual property rights, such as copyrights, patents, trademarks, industrial designs, and trade secrets.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/United_States">United States</a></td>
      <td>The United States of America (U.S.A. or USA), commonly known as the United States (U.S. or US) or America, is a country primarily located in North America. It consists of 50 states, a federal district, five major unincorporated territories, 326 Indian reservations, and nine minor outlying islands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_states_and_territories_of_the_United_States">List of states and territories of the United States</a></td>
      <td>The United States of America is a federal republic consisting of 50 states, a federal district (Washington, D.C., the capital city of the United States), five major territories, and various minor islands. The 48 contiguous states and Washington, D.C., are in North America between Canada and Mexico.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/United_States_dollar">United States dollar</a></td>
      <td>The United States dollar (symbol: $; code: USD; also abbreviated US$ or U.S. Dollar, to distinguish it from other dollar-denominated currencies; referred to as the dollar, U.S. dollar, American dollar, or colloquially buck) is the official currency of the United States and several other countries. The Coinage Act of 1792 introduced the U.S. dollar at par with the Spanish silver dollar, divided it into 100 cents, and authorized the minting of coins denominated in dollars and cents.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>BALCHEM CORP    Item 1A Risk Factors          This Report contains   &amp;quote forward-looking  statements &amp;quote   within the meaning of  Section 21E of the  Securities  Exchange Act of 1934, as amended,  which reflect  our  <font color="blue">expectation</font>  or belief  <font color="blue">concerning</font>  future  events that  involve  risks and  <font color="blue">uncertainties</font></td>
    </tr>
    <tr>
      <td>We can  not  assure  you  that  the  <font color="blue">expectation</font>s  reflected  in  forward-looking  statements  will prove  correct</td>
    </tr>
    <tr>
      <td><font color="blue">Various  </font>factors  could cause  results to <font color="blue">differ materially from</font> our <font color="blue">expectation</font>s, such as:          o     changes in laws or <font color="blue"><font color="blue">regulations</font> affecting</font> our <font color="blue">operations</font>;          o     changes in our business tactics or strategies;          o     <font color="blue">acquisitions</font> of new or complementary <font color="blue">operations</font>;          o     sales of any of our existing <font color="blue">operations</font>;          o     changing <font color="blue">market forces</font> or  <font color="blue">contingencies</font>  that  <font color="blue">necessitate</font>,  in our              judgment, changes in our plans, strategy or tactics; and          o     <font color="blue">fluctuations</font>  in the  <font color="blue">investment</font>  markets or interest  rates,  which              <font color="blue">might materially affect</font> our <font color="blue">operations</font> or <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>In addition,  the <font color="blue">following matters</font>,  and all forward-looking  statements,  are qualified in their <font color="blue">entirety by</font> these <font color="blue">cautionary statements</font>:          <font color="blue">Increased </font><font color="blue"><font color="blue">competition</font> would hurt</font> our business and financial results</td>
    </tr>
    <tr>
      <td>We face  <font color="blue">competition</font>  in our  markets  from a number  of large  and  small  companies,  some of which have  greater  financial,  research  and  <font color="blue">development</font>,  production  and other  <font color="blue">resources than</font> we do</td>
    </tr>
    <tr>
      <td>Our  <font color="blue">competitive</font>  position is based  <font color="blue">principally on</font>  performance,  quality,  customer  support,  service,  breadth of  <font color="blue">product line</font>,  <font color="blue">manufacturing</font>  or packaging  <font color="blue">technology</font> and the <font color="blue">selling prices</font> of  our  products</td>
    </tr>
    <tr>
      <td>Our  <font color="blue">competitors</font>  can be  expected  to  improve  the  design and  performance  of their  products and to <font color="blue">introduce new products</font>  with  <font color="blue">competitive</font>  price and performance  <font color="blue">characteristics</font></td>
    </tr>
    <tr>
      <td>We may not have <font color="blue">sufficient resources</font> to  maintain our current <font color="blue">competitive</font> position or market share</td>
    </tr>
    <tr>
      <td>One of our customers  <font color="blue">accounts</font> for about 10prca of our business;  the loss of  that <font color="blue">customer could</font> <font color="blue">adversely</font> impact our business and financial results</td>
    </tr>
    <tr>
      <td>Due to <font color="blue">consolidation</font> of customer <font color="blue">businesses</font> in the contract  <font color="blue">sterilization</font>  industry,  we  have  one  specialty  products  customer,   which  accounted  for  <font color="blue">approximately</font> 9prca and 11prca of our net sales in 2005 and 2004,  <font color="blue">respectively</font></td>
    </tr>
    <tr>
      <td>This  customer  accounted  for 8prca and 10prca of our  <font color="blue">accounts</font>  receivable  <font color="blue">net balance at</font>  <font color="blue">December </font>31, 2005 and 2004, <font color="blue">respectively</font></td>
    </tr>
    <tr>
      <td>The loss of this <font color="blue">customer could</font> have a  material adverse effect on our business and financial results</td>
    </tr>
    <tr>
      <td>6  <PAGE>          The loss of <font color="blue">governmental</font>  permits and <font color="blue">approvals would materially harm</font> some  of our <font color="blue">businesses</font></td>
    </tr>
    <tr>
      <td>Pursuant to applicable  <font color="blue">environmental</font> and safety laws and <font color="blue">regulations</font>,  we  are required to obtain and maintain certain  <font color="blue">governmental</font> permits and approvals,  including an EPA  <font color="blue">registration</font>  for our ethylene  oxide  sterilant  product</td>
    </tr>
    <tr>
      <td>We  maintain an EPA <font color="blue">registration</font> of <font color="blue"><font color="blue">ethylene oxide</font> as</font> a medical device sterilant and  fumicide</td>
    </tr>
    <tr>
      <td>We are in the process of  re-registering  this product in  <font color="blue">accordance</font>  with  FIFRA  There  is  no  guaranty  that  the  EPA  will  continue  to  allow  <font color="blue">registration</font> of <font color="blue">ethylene oxide</font> for the uses mentioned  above</td>
    </tr>
    <tr>
      <td>The failure of the  EPA to allow  re-<font color="blue">registration</font>  of ethylene  oxide would have a material  adverse  impact on our business</td>
    </tr>
    <tr>
      <td>Our Channahon,  Illinois  <font color="blue">manufacturing</font>  <font color="blue"><font color="blue">facility</font> <font color="blue">manufacture</font>s</font> our calcium  <font color="blue">carbonate line</font> of <font color="blue">pharmaceutical</font>  <font color="blue">ingredients</font></td>
    </tr>
    <tr>
      <td>This <font color="blue">facility</font> is <font color="blue">registered with</font>  the <font color="blue">United States </font>Food and Drug  Administration  ( &amp;quote FDA &amp;quote ) as a drug <font color="blue">manufacturing</font>  <font color="blue">facility</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">products also must</font> be  <font color="blue"><font color="blue">manufacture</font>d</font>  in <font color="blue">conformity with current</font>  Good  Manufacturing  Practice (cGMP)  <font color="blue">regulations</font> as interpreted and <font color="blue">enforced by</font>  the FDA Modifications,  <font color="blue">enhancements</font> or changes in <font color="blue">manufacturing</font>  <font color="blue">facilities</font> or  procedures of our <font color="blue">pharmaceutical</font> products are, in many <font color="blue">circumstances</font>, subject to  FDA approval,  which may be subject to a <font color="blue">lengthy application process</font> or which we  may be unable to obtain</td>
    </tr>
    <tr>
      <td>Our Channahon,  Illinois <font color="blue">facility</font>,  as well as those of  any third-party cGMP <font color="blue">manufacture</font>rs that we may use, are <font color="blue">periodically</font>  subject to  <font color="blue">inspection by</font> the FDA and other <font color="blue">governmental</font>  agencies,  and <font color="blue">operations</font> at these  <font color="blue">facilities</font>  could be <font color="blue">interrupted</font>  or halted if the results of these  <font color="blue">inspections</font>  are unsatisfactory</td>
    </tr>
    <tr>
      <td>Failure to comply with FDA or other <font color="blue">governmental</font> <font color="blue">regulations</font>  can result in fines, unanticipated compliance expenditures, recall or seizure of  products,  total or  partial  suspension  of  production,  <font color="blue">enforcement</font>  actions,  <font color="blue">injunctions</font> and <font color="blue">criminal prosecution</font></td>
    </tr>
    <tr>
      <td>Permits and approvals may be subject to revocation, <font color="blue">modification</font> or denial  under certain <font color="blue">circumstances</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">operations</font> or <font color="blue">activities</font> (including the status  of  compliance  by the  prior  owner  of the  Verona,  Missouri  <font color="blue">facility</font>  under  <font color="blue">Superfund  </font><font color="blue">remediation</font>)  could  result in  <font color="blue">administrative</font>  or  private  actions,  revocation  of required  permits or  licenses,  or fines,  penalties or damages,  <font color="blue">which could</font> have an adverse  effect on us</td>
    </tr>
    <tr>
      <td>In  addition,  we can not predict the  extent to which any  <font color="blue">legislation</font>  or  regulation  may  affect the market for our  products or our cost of doing business</td>
    </tr>
    <tr>
      <td>Raw  material  shortages or price  increases  would  <font color="blue">adversely</font>  affect our  business and financial results</td>
    </tr>
    <tr>
      <td>The <font color="blue">principal <font color="blue">raw materials</font></font> that we use in the <font color="blue">manufacture</font> of our products  can be subject to price  <font color="blue">fluctuations</font></td>
    </tr>
    <tr>
      <td>While the <font color="blue">selling prices</font> of our products  tend to  increase or decrease  over time with the cost of raw  materials,  these  changes may not occur  <font color="blue">simultaneously</font> or to the same degree</td>
    </tr>
    <tr>
      <td>At times, we may be  unable to pass  increases in raw material  <font color="blue">costs through</font> to our customers in the  form of <font color="blue">price increases</font></td>
    </tr>
    <tr>
      <td><font color="blue">Increases </font>in the price of <font color="blue">raw materials</font>, if not offset  by product <font color="blue">price increases</font>,  would have an <font color="blue">adverse impact on</font> our  <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>We are not experiencing any current  <font color="blue">difficulties</font> in procuring <font color="blue">raw materials</font> and  we do not anticipate any <font color="blue">such problems</font></td>
    </tr>
    <tr>
      <td>However, we can not assure you that this  <font color="blue">will always</font> be the case</td>
    </tr>
    <tr>
      <td>Our financial  success  depends in part on the <font color="blue">reliability</font> and <font color="blue">sufficiency</font>  of our <font color="blue">manufacturing</font> <font color="blue">facilities</font></td>
    </tr>
    <tr>
      <td>Our  revenues  <font color="blue">depend on</font> the  continued  operation  of our  <font color="blue">manufacturing</font>,  packaging,  and processing <font color="blue">facilities</font></td>
    </tr>
    <tr>
      <td>The operation of our <font color="blue">facilities</font> involves  risks,  including  the  <font color="blue">breakdown</font>,   failure,  or  substandard   performance  of  equipment, power outages, the <font color="blue">improper installation</font>,  or operation of equipment,  <font color="blue">explosions</font>,  fires,  <font color="blue">natural disasters</font> and the need to comply with <font color="blue">environmental</font>  and other  <font color="blue">directives</font>  of  <font color="blue">governmental</font>  agencies</td>
    </tr>
    <tr>
      <td>The  occurrence  of material  operational  problems,  including  but not  limited to the above  events,  could  <font color="blue">adversely</font>  affect  our  <font color="blue">profitability</font>  during  the  period  of such  operational  <font color="blue">difficulties</font></td>
    </tr>
    <tr>
      <td>7  <PAGE>          Our failure or <font color="blue">inability</font> to protect our  <font color="blue">intellectual</font>  <font color="blue">property could harm</font>  our business and financial results</td>
    </tr>
    <tr>
      <td>We hold 15 patents in the <font color="blue">United States </font>and  overseas,  as well as utilize  certain  unpatented  trade  secrets</td>
    </tr>
    <tr>
      <td>Third  parties  could  seek to  challenge,  invalidate or <font color="blue">circumvent</font> our patents</td>
    </tr>
    <tr>
      <td>Moreover, there could be successful claims  <font color="blue">against us</font> alleging that we infringe the <font color="blue">intellectual</font> property rights of others</td>
    </tr>
    <tr>
      <td>If we are unable to protect all of our <font color="blue">intellectual</font>  property  rights,  or if we  are found to be infringing the  <font color="blue">intellectual</font>  property  rights of others,  there  could  be  an  adverse  effect  on  our  business  and  financial  results</td>
    </tr>
    <tr>
      <td><font color="blue">Competitors </font>could  <font color="blue">independently</font> develop <font color="blue">substantially</font>  <font color="blue">equivalent proprietary</font>  information,  which  <font color="blue">could hurt</font> our business and financial results</td>
    </tr>
    <tr>
      <td>We <font color="blue">face risks</font>  associated  with our sales to customers  outside the United  States</td>
    </tr>
    <tr>
      <td>For the year ended  <font color="blue">December </font>31, 2005,  <font color="blue">approximately</font>  7prca of our net sales  consisted of <font color="blue">sales outside</font> the United States, <font color="blue">predominately</font> to Europe, Japan and  Mexico</td>
    </tr>
    <tr>
      <td>Such sales are <font color="blue">generally denominated</font> in US Dollars at a <font color="blue">specific price</font>  per unit</td>
    </tr>
    <tr>
      <td>Changes in the relative  values of currencies take place from time to  time and could in the future  <font color="blue">adversely</font>  affect  prices  foreign  customers  are  willing to pay for our products</td>
    </tr>
    <tr>
      <td>In addition, <font color="blue">international sales</font> are subject to  other <font color="blue">inherent risks</font>,  including <font color="blue">possible labor unrest</font>,  political  <font color="blue">instability</font>,  <font color="blue">export duties</font> and quotas</td>
    </tr>
    <tr>
      <td>These <font color="blue">factors could</font> have a material <font color="blue">adverse impact on</font>  our ability to increase or maintain our <font color="blue">international sales</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">success depends</font> in large part on our <font color="blue">key personnel</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">operations</font> significantly <font color="blue">depend on</font> the <font color="blue">continued efforts</font> of our senior  <font color="blue">executives</font></td>
    </tr>
    <tr>
      <td>The loss of the  services  of certain  <font color="blue">executives</font>  for an  extended  period  of time  could  have a  material  adverse  effect  on our  business  and  financial results</td>
    </tr>
    <tr>
      <td><font color="blue">Litigation  </font>can be  costly  and can  <font color="blue">adversely</font>  affect  our  business  and  financial results</td>
    </tr>
    <tr>
      <td>We, like all <font color="blue">companies involved</font> in the food and <font color="blue">pharmaceutical</font> industries,  are subject to potential claims for <font color="blue">product liability</font>  relating to our products</td>
    </tr>
    <tr>
      <td>Such claims,  <font color="blue">irrespective</font> of their outcomes or merits,  could be time-consuming  and expensive to defend,  and could result in the  diversion of <font color="blue">management</font>  time  and attention</td>
    </tr>
  </tbody>
</table>